Treatment of Childhood Non-Hodgkin’s Lymphomas: Trends in Europe

  • Catherine Patte
Conference paper
Part of the ESO Intercity Report book series (ESO INTERCITY)

Abstract

In the past decade, there have been major advances in the treatment of children with non-Hodgkin’s lymphoma (NHL). On the one hand, biological and immunological characterisation has contributed significantly to our understanding of these disorders. On the other, the observation that lymphomas are a heterogeneous group of diseases with differing clinical presentations and histological subgroups and, above all, optimal response to different treatment regimens, has led to better schemes of treatment based on intensive polychemotherapy.

Keywords

Europe Lymphoma Oncol Dexamethasone Methotrexate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lennert K, Mohri N: Histopathology and diagnosis of non-Hodgkin’s lymphomas. In: Lennert K et al (eds) Malignant Lymphomas Other than Hodgkin’s Disease. Springer Verlag, New York, 1978Google Scholar
  2. 2.
    National Cancer Institute-sponsored study of classification of non-Hodgkin’s lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982 (49):2112–2135CrossRefGoogle Scholar
  3. 3.
    Bernard A, Boumsell L, Bayle C et al: Subsets of malignant lymphomas in children related to the cell phenotype. Blood 1979 (54):1058–1068PubMedGoogle Scholar
  4. 4.
    Lemerle J, Bernard A, Patte C et al: Malignant B-cell lymphomas of childhood. In: Barrett A, Bloom HJG, Lemerle J et al (eds) Cancer in Children. Clinical Management (2nd edition). UICC Handbook, Springer Verlag, Heidelberg 1986 pp 37–51Google Scholar
  5. 5.
    Amylon MD, Link MP and Murphy SB: Malignant T-cell and other non-Hodgkin’s lymphoma. In: Barrett A, Bloom HJG, Lemerle J et al (eds) Cancer in Children. Clinical Management (2nd edition). UICC Handbook, Springer Verlag, Heidelberg 1986 pp 152–163Google Scholar
  6. 6.
    Patte C, Bernard A, Bayle C: Lymphomes malins non Hodgkiniens. Med Infant 1988 (8):817–834Google Scholar
  7. 7.
    Murphy SB, Hustu HO: A randomized trial of combined modality therapy of childhood non-Hodgkin’s lymphoma. Cancer 1980 (45):630–637PubMedCrossRefGoogle Scholar
  8. 8.
    Patte C, Rodary C, Sarrazin D et al: Résultat du traitement de 178 lymphomes malins non Hodgkiniens de l’enfant de 1973 à 1978. Arch Fr Pediatr 1981 (38):321–327PubMedGoogle Scholar
  9. 9.
    Lemerle J: The treatment of B-cell non-Hodgkin’s malignant lymphomas of childhood in Europe. Recent and on-going studies. In: Lenoir JM, O’Connor G, Olweny CLM (eds) Burkitt’s Lymphoma, a Human Cancer Model. IARC Scient Publ No 60, Lyon 1985 pp 383–398Google Scholar
  10. 10.
    Philip T, Lenoir GM, Bryon PA et al: Burkitt type malignant lymphoma in France: individualisation among Caucasian childhood non-Hodgkin’s lymphoma. Br J Cancer 1982 (45):670–678PubMedCrossRefGoogle Scholar
  11. 11.
    Muller-Weirich ST, Henze G, Odenwald E et al: BFM trials for childhood non-Hodgkin’s lymphoma. In: Cavalli F, Bonadonna G, Rozencweig G (eds): Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances. Martinus Nijhoff, Boston 1985 pp 633–642CrossRefGoogle Scholar
  12. 12.
    Anderson JR, Wilson JR, Jenkin DT: Childhood non-Hodgkin’s lymphoma: results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) to a 10-drug regimen (LSA2L2). N Engl J Med 1983 (308):559–565PubMedCrossRefGoogle Scholar
  13. 13.
    Wollner N, Exelby PR, Lieberman PH: Non-Hodgkin’s lymphomas in children. A progress report on the original patients treated with the LSA2L2 protocol. Cancer 1979 (44) :1990–1999PubMedCrossRefGoogle Scholar
  14. 14.
    Jenkin RDT, Anderson JR, Chilcote RR, Coccia P, Exelby P, Kersey J, Kjeldsberg CR, Kushner J, Meadows AT, Siegel S, Wilson JF, Hammond D: The treatment of diffuse undifferentiated non-Hodgkin’s lymphoma in children: the children’s cancer study group experience. In: Lenoir JM, O’Connor G, Olweny CLM (eds) Burkitt’s Lymphoma, a Human Cancer Model. IARC Scient Publ No 60, Lyon 1985 pp 399–404Google Scholar
  15. 15.
    Murphy SB: Management of childhood non-Hodgkin’s lymphoma. Cancer Treat Rep 1977 (61):1161–1173PubMedGoogle Scholar
  16. 16.
    Jenkin RDT, Anderson JR, Chilcote RR, Coccia PF, Exelby PR, Kersey JH, Kushner JH, Meadows AT, Siegel SE, Wilson JF, Hammond GD: The treatment of localized non-Hodgkin’s lymphoma in children: a report from the children’s cancer study group. J Clin Oncol 1984 (2) :88–97PubMedGoogle Scholar
  17. 17.
    Murphy SB, Hustu HO, Rivera G, Berard CW: End results of treating children with localized non-Hodgkin’s lymphomas with a combined modality approach of lessened intensity. J Clin Oncol 1983 (1):326–330PubMedGoogle Scholar
  18. 18.
    Mott MG, Eden OB, Hann I for the UKCCSG: Curability of localised non-Hodgkin’s lymphoma of childhood (NHL) without radiation. Med Ped Oncol 1988 (16):423 (abstract)Google Scholar
  19. 19.
    Gasparini M, Lombardi F, Fossati-Bellani F, Gianni C, Rottoli L: Localized non-Hodgkin’s lymphoma (NHL) in children: results of a prospective treatment program including radiotherapy. Med Ped Oncol 1988 (16):421 (abstract)Google Scholar
  20. 20.
    Patte C, Philip T, Rodary C et al: Improved survival rate in children with stage III and IV B-cell non-Hodgkin’s lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 1986 (4):1219–1226PubMedGoogle Scholar
  21. 21.
    Patte C, Philip T, Rodary C, Zucker JM, Olive D, Beard C, Harousseau JL, Behrendt, Vannier JP, Pautard B, Demeocq F, for the SFOP: Updated results of the protocol LMB84 of the French Pediatriac Oncology Society (SFOP): randomized study to shorten duration of treatment of advanced stage B-cell non-Hodgkin’s lymphoma (NHL) without CNS involvement. Med Ped Oncol 1988 (16):406 (abstract)Google Scholar
  22. 22.
    Patte C, Philip T, Zucker JM, Leverger G, Rubie H, Otten J, Benz-Lemoine E, on behalf of the SFOP: Results of the LMB86 protocol of the French Pediatric Oncology Society (SFOP) for B-cell non-Hodgkin’s lymphoma (B-NHL) with CNS involvement (CNS+) and B-ALL. Proc ASCO J Clin Oncol 1989 (8) abstract No 1090Google Scholar
  23. 23.
    Müller-Weihrich ST, Ludwig R, Reiter A, Ritter J, Schrappe M, Riehm H: B-type non-Hodgkin’s lymphomas and leukemia: the BFM study group experience. Proc of the Third International Conference on Malignant Lymphoma, Lugano 1987, abstract No 43, p 42Google Scholar
  24. 24.
    Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, Pui CH, Fairclough D, Berard CW: Results of treatment of advanced-stage Burkitt’s lymphoma and B-cell (Sig+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986 (4):1732–1739PubMedGoogle Scholar
  25. 25.
    Gasparini M, Rottoli L, Gianni C, Morandi F, Ballerini E, Fossati-Bellani F: Intensive short-term chemotherapy for advanced childhood Burkitt-type non-Hodgkin’s lymphoma (B-NHL). Proc of the Third International Conference on Malignant Lymphoma, Lugano 1987, abstract No 47, p 44Google Scholar
  26. 26.
    Pacquement H, Asselin B, Quintana E, Dumont J, Mathiot C, Michon J, Zucker JM: Study of 24 children with non-B lymphoma treated in a single institution with a modified scheme of the German BFM. Med Ped Oncol 1988 (16):424 (abstract)Google Scholar
  27. 27.
    Guidicelli J, Bertrand Y, Paris A, Clerc M, Manel AM, Durin A: Treatment of malignant lymphomas with BFM-like regimen. Results about 12 cases. Med Ped Oncol 1988 (16):418 (abstract)Google Scholar
  28. 28.
    Pichler E, Jurgenssen O, Radaskiewicz T et al: Results of LSA2 L2 therapy in 26 children with non-Hodgkin’s lymphoma. Cancer 1982 (50):2740–2746PubMedCrossRefGoogle Scholar
  29. 29.
    Otten J, Benoit Y, Casteels-Vandaele M et al: Non-Hodgkin’s lymphoma in children. A preliminary report of a study by the Belgian Cooperative Group for the treatment of solid tumours in children. Acta Pediatr Belg 1981 (34):157–164Google Scholar
  30. 30.
    Boguslawska-Jaworska J, Sonta-Jakimczyk D, Armata J, Rodziewicz B, Kazanowska B, Ochocka M, Rokicka-Milewska R, Radwanska U: The results of therapy in non-Hodgkin’s lymphoma in children. A report on behalf of the Polish children’s leukemia/lymphoma study group. Med Ped Oncol 1988 (16):419 (abstract)Google Scholar
  31. 31.
    Bezanilla Regato JL, Navajas A, Moya E, Lizarraga M: Modified LSA2L2 protocol in the treatment of twenty-six non-Hodgkin’s lymphoma (NHL) children. Med Ped Oncol 1988 (16):442 (abstract)Google Scholar
  32. 32.
    Tzortzatou F, Mikraki V, Polychronopoulou S, Panayiotou J, Galanakis S, Vrachnou E, Tsomi K: Non-Hodgkin’s lymphoma in childhood: a report of 49 cases. Med Ped Oncol 1988 (16):443 (abstract)Google Scholar
  33. 33.
    Vecchi V, Pession A, Serra L et al: Non-Hodgkin’s lymphoma in children: results of treatment with the modified LSA2-L2 protocol. Med Ped Oncol 1981 (9):483–491CrossRefGoogle Scholar
  34. 34.
    Patte C, Kalifa C, Bernard A, Hartmann O, Flamant F, Brugière L, Caillaud JM, Bayle C, Rodary C, Lemerle J: Non-Hodgkin’s lymphoma (NHL) in childhood: improvement of survival and ONS prophylaxis in two consecutive studies. Med Ped Oncol 1988 (16):388 (abstract)Google Scholar
  35. 35.
    Patte C, Kalifa C, Bernard A, Hartmann O, Flamant F, Caillaud JM, Bayle C, Lemerle J: LSA2L2 protocol modified by the adjunction of high dose methotrexate (HD MTX): results on 47 children with lymphoblastic non-Hodgkin’s lymphomas. Proc of the XVIII Annual Meeting of SIOP, 1986, p 66Google Scholar
  36. 36.
    Biron P, Philip T, Meziane F, Bouffet E, Rebattu P, Frappaz D, Colin C, Brunat-Mentigny M: T lymphoblastic and immunoblastic lymphoma treated with a modification of LSA2L2: 78% relapse-free survival at 36 months. Med Ped Oncol 1988 (16):419 (abstract)Google Scholar
  37. 37.
    Dluzniewska A, Depowska T, Armata J: “Smouldering” and symptomatic forms of central nervous system involvement in the course of non-Hodgkin’s lymphoma in children. Folia Haematol Leipzig 1985 (2):241–247Google Scholar
  38. 38.
    Benz-Lemoine E, Leverger G, Bancillon A, Schmitt C, Lamagnere JP, Taboureau O, Perel Y, Schalson G: Treatment of thoracic lymphoblastic lymphoma and acute lymphoblastic leukemia (ALL) with mediastinal mass. Results of “high-risk Fraile 83” protocol in 67 children. Med Ped Oncol 1988 (16):386 (abstract)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • Catherine Patte
    • 1
  1. 1.Department of PaediatricsInstitut Gustave-RoussyVillejuifFrance

Personalised recommendations